The Indian government is considering regulatory revisions for the MedTech and pharma sectors and has sought input from the industry. Niti Aayog member VK Paul highlighted the need to update the regulatory framework to support advancements in medical technology and pharma, aiming for enhanced exports and innovation.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QyVP3OY
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Government looking to tweak regulatory norms for MedTech, pharma sectors: Niti Aayog's VK Paul
0 comments:
Post a Comment